 |
인쇄하기
취소
|
Detailed screening guideline on combination product makes public
The detailed screening rules on the license application of generic combination products have been disclosed recently.
In an information session on December 3, officials at the Korea Food and Drug Administration provided the detailed screening guideline on the license application on combined drugs for treatment of circulatory disorder, slow-release preparations and antineoplastic agents.
A...
In an information session on December 3, officials at the Korea Food and Drug Administration provided the detailed screening guideline on the license application on combined drugs for treatment of circulatory disorder, slow-release preparations and antineoplastic agents.
A...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.